select search filters
briefings
roundups & rapid reactions
before the headlines
Fiona fox's blog

Tag search results

Ketamine and depression

Severe depression is the number one psychological disorder in the UK and yet 30% of patients do not respond to … read more

Can we make cannabis safer?

In a Personal View article to be published in the Lancet Psychiatry, the authors explain that increasingly liberal cannabis laws in some countries and the increasing potency of cannabis worldwide mean that we need to think about whether and how cannabis can be made safer.

read more

expert reaction to study on cannabis vaping using e-cigarettes

Cannabis is a class B drug in the UK but is in use for therapeutic purposes in a number of countries for various diseases, and a paper published in the journal Scientific Reports has reported that e-cigarette devices could be effective in administering therapeutic doses of the drug. read more

Psilocybin – an option for treatment-resistant depression?

Psilocybin, the active component of magic mushrooms, is being seriously considered as a therapy for people with treatment-resistant depression. One in five people suffer from depression at some point in their lives – a significant proportion of whom cannot be helped with any current psychotherapy or drugs. In 2012 researchers published a paper which used fMRI scans to show the effects of psilocybin on the brain. A related paper, published at the same time, suggested that psilocybin could be a useful tool in psychotherapy. The researchers have now gone on to test the safety of psilocybin in a small group of patients with treatment-resistant depression. They are publishing their new findings, funded by the Medical Research Council, in The Lancet Psychiatry. read more

expert reaction to psilocybin and treatment-resistant depression

Psilocybin, the active component of magic mushrooms, is being seriously considered as a therapy for people with treatment-resistant depression. Publishing in The Lancet Psychiatry journal a group researchers have now gone on to test the safety of psilocybin in a small group of patients with treatment-resistant depression. read more

search by tag

see the latest